Sevuparin blocks sickle blood cell adhesion and sickle‐leucocyte rolling on immobilized L‐selectin in a dose dependent manner

Abstract

advanced-stage Hodgkin’s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet, 390, 2790–2802. Budczies, J., Klauschen, F., Sinn, B.V., Gyorffy, B., Schmitt, W.D., Darb-Esfahani, S. & Denkert, C. (2012) Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS ONE, 7, e51862. Hao, X., Wei, Y., Wei, X., Zhou, L., Wei, Q., Zhang, Y., Huang, W. & Feng, R. (2017) Glasgow prognostic score is superior to other inflammationbased scores in predicting survival of diffuse large B-cell lymphoma. Oncotarget, 8, 76740–76748. Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. (2008) Cancer-related inflammation. Nature, 454, 436–444. Marcheselli, R., Bari, A., Tadmor, T., Marcheselli, L., Cox, M.C., Pozzi, S., Ferrari, A., Baldini, L., Gobbi, P., Aviv, A., Pugliese, G., Federico, M., Polliack, A. & Sacchi, S. (2017) Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients. Hematological Oncology, 35, 561–566. Reddy, J.P., Hernandez, M., Gunther, J.R., Dabaja, B.S., Martin, G.V., Jiang, W., Akhtari, M., Allen, P.K., Atkinson, B.J., Smith, G.L., Pinnix, C.C., Milgrom, S.A., Abou Yehia, Z., Osborne, E.M., Oki, Y., Lee, H., Hagemeister, F. & Fanale, M.A. (2017) Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma. British Journal of Haematology, 180, 545–549. Skinnider, B.F. & Mak, T.W. (2002) The role of cytokines in classical Hodgkin lymphoma. Blood, 99, 4283–4297. Tadmor, T., Bari, A., Marcheselli, L., Sacchi, S., Aviv, A., Baldini, L., Gobbi, P.G., Pozzi, S., Ferri, P., Cox, M.C., Cascavilla, N., Iannitto, E., Federico, M. & Polliack, A. (2015) Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis hodgkin lymphoma: evaluation based on data from 1450 patients. Mayo Clinic Proceedings, 90, 756–764. Zinzani, P.L., Broccoli, A., Gioia, D.M., Castagnoli, A., Ciccone, G., Evangelista, A., Santoro, A., Ricardi, U., Bonfichi, M., Brusamolino, E., Rossi, G., Anastasia, A., Zaja, F., Vitolo, U., Pavone, V., Pulsoni, A., Rigacci, L., Gaidano, G., Stelitano, C., Salvi, F., Rusconi, C., Tani, M., Freilone, R., Pregno, P., Borsatti, E., Sacchetti, G.M., Argnani, L. & Levis, A. (2016) Interim positron emission tomography response-adapted therapy in advanced-stage hodgkin lymphoma: Final results of the phase II part of the HD0801 study. Journal of Clinical Oncology, 34, 1376–1385.